nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—Folic Acid Metabolism Inhibitors—Methotrexate—multiple sclerosis	0.384	1	CiPCiCtD
Pemetrexed—Methotrexate—multiple sclerosis	0.249	1	CrCtD
Pemetrexed—DCK—Cladribine—multiple sclerosis	0.046	0.305	CbGbCtD
Pemetrexed—ATIC—Methotrexate—multiple sclerosis	0.0395	0.262	CbGbCtD
Pemetrexed—Tetrahydrofolic acid—Methotrexate—multiple sclerosis	0.0329	0.2	CrCrCtD
Pemetrexed—Folic Acid—Methotrexate—multiple sclerosis	0.0329	0.2	CrCrCtD
Pemetrexed—Leucovorin—Methotrexate—multiple sclerosis	0.0329	0.2	CrCrCtD
Pemetrexed—Raltitrexed—Methotrexate—multiple sclerosis	0.0329	0.2	CrCrCtD
Pemetrexed—Pralatrexate—Methotrexate—multiple sclerosis	0.0329	0.2	CrCrCtD
Pemetrexed—SLC46A1—Methotrexate—multiple sclerosis	0.0314	0.208	CbGbCtD
Pemetrexed—DHFR—Methotrexate—multiple sclerosis	0.0201	0.133	CbGbCtD
Pemetrexed—TYMS—Methotrexate—multiple sclerosis	0.014	0.0926	CbGbCtD
Pemetrexed—ATIC—leg—multiple sclerosis	0.00211	0.158	CbGeAlD
Pemetrexed—DHFR—Nucleotide Metabolism—SRM—multiple sclerosis	0.000811	0.0914	CbGpPWpGaD
Pemetrexed—GART—medulla oblongata—multiple sclerosis	0.000505	0.0378	CbGeAlD
Pemetrexed—ATIC—brainstem—multiple sclerosis	0.000492	0.0368	CbGeAlD
Pemetrexed—GART—Nucleotide metabolism—RRM1—multiple sclerosis	0.000483	0.0544	CbGpPWpGaD
Pemetrexed—ATIC—retina—multiple sclerosis	0.000475	0.0355	CbGeAlD
Pemetrexed—GART—midbrain—multiple sclerosis	0.000462	0.0346	CbGeAlD
Pemetrexed—GART—spinal cord—multiple sclerosis	0.000451	0.0337	CbGeAlD
Pemetrexed—DHFR—Nucleotide Metabolism—RRM1—multiple sclerosis	0.000433	0.0488	CbGpPWpGaD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000412	0.0464	CbGpPWpGaD
Pemetrexed—GART—nervous system—multiple sclerosis	0.00038	0.0284	CbGeAlD
Pemetrexed—SLC46A1—spinal cord—multiple sclerosis	0.000366	0.0274	CbGeAlD
Pemetrexed—GART—central nervous system—multiple sclerosis	0.000365	0.0274	CbGeAlD
Pemetrexed—GART—cerebellum—multiple sclerosis	0.000357	0.0267	CbGeAlD
Pemetrexed—ATIC—Nucleotide metabolism—RRM1—multiple sclerosis	0.000335	0.0377	CbGpPWpGaD
Pemetrexed—DHFR—retina—multiple sclerosis	0.000319	0.0239	CbGeAlD
Pemetrexed—ATIC—midbrain—multiple sclerosis	0.000314	0.0235	CbGeAlD
Pemetrexed—SLC46A1—nervous system—multiple sclerosis	0.000308	0.0231	CbGeAlD
Pemetrexed—ATIC—spinal cord—multiple sclerosis	0.000306	0.0229	CbGeAlD
Pemetrexed—SLC46A1—central nervous system—multiple sclerosis	0.000297	0.0222	CbGeAlD
Pemetrexed—GART—brain—multiple sclerosis	0.00029	0.0217	CbGeAlD
Pemetrexed—SLC46A1—cerebellum—multiple sclerosis	0.00029	0.0217	CbGeAlD
Pemetrexed—DHFR—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000279	0.0314	CbGpPWpGaD
Pemetrexed—DCK—retina—multiple sclerosis	0.000276	0.0206	CbGeAlD
Pemetrexed—ATIC—nervous system—multiple sclerosis	0.000258	0.0193	CbGeAlD
Pemetrexed—ATIC—central nervous system—multiple sclerosis	0.000248	0.0186	CbGeAlD
Pemetrexed—TYMS—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000243	0.0274	CbGpPWpGaD
Pemetrexed—ATIC—cerebellum—multiple sclerosis	0.000243	0.0182	CbGeAlD
Pemetrexed—SLC46A1—brain—multiple sclerosis	0.000236	0.0176	CbGeAlD
Pemetrexed—DHFR—medulla oblongata—multiple sclerosis	0.00023	0.0172	CbGeAlD
Pemetrexed—GART—Folate Metabolism—IL4—multiple sclerosis	0.000226	0.0254	CbGpPWpGaD
Pemetrexed—TYMS—midbrain—multiple sclerosis	0.000213	0.0159	CbGeAlD
Pemetrexed—DHFR—midbrain—multiple sclerosis	0.000211	0.0158	CbGeAlD
Pemetrexed—DHFR—spinal cord—multiple sclerosis	0.000205	0.0154	CbGeAlD
Pemetrexed—DCK—medulla oblongata—multiple sclerosis	0.000199	0.0149	CbGeAlD
Pemetrexed—ATIC—brain—multiple sclerosis	0.000197	0.0147	CbGeAlD
Pemetrexed—DCK—midbrain—multiple sclerosis	0.000182	0.0136	CbGeAlD
Pemetrexed—GART—Folate Metabolism—ICAM1—multiple sclerosis	0.000179	0.0202	CbGpPWpGaD
Pemetrexed—DCK—spinal cord—multiple sclerosis	0.000178	0.0133	CbGeAlD
Pemetrexed—TYMS—nervous system—multiple sclerosis	0.000175	0.0131	CbGeAlD
Pemetrexed—DCK—Nucleotide metabolism—RRM1—multiple sclerosis	0.000174	0.0196	CbGpPWpGaD
Pemetrexed—DHFR—nervous system—multiple sclerosis	0.000173	0.013	CbGeAlD
Pemetrexed—TYMS—central nervous system—multiple sclerosis	0.000168	0.0126	CbGeAlD
Pemetrexed—DHFR—central nervous system—multiple sclerosis	0.000167	0.0125	CbGeAlD
Pemetrexed—TYMS—cerebellum—multiple sclerosis	0.000165	0.0123	CbGeAlD
Pemetrexed—DHFR—cerebellum—multiple sclerosis	0.000163	0.0122	CbGeAlD
Pemetrexed—GART—Folate Metabolism—CCL2—multiple sclerosis	0.00016	0.0181	CbGpPWpGaD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.00016	0.018	CbGpPWpGaD
Pemetrexed—SLC29A1—nervous system—multiple sclerosis	0.000157	0.0117	CbGeAlD
Pemetrexed—SLC29A1—central nervous system—multiple sclerosis	0.000151	0.0113	CbGeAlD
Pemetrexed—DCK—nervous system—multiple sclerosis	0.00015	0.0112	CbGeAlD
Pemetrexed—GART—Folate Metabolism—ALB—multiple sclerosis	0.00015	0.0168	CbGpPWpGaD
Pemetrexed—DHFR—E2F transcription factor network—RRM1—multiple sclerosis	0.000148	0.0166	CbGpPWpGaD
Pemetrexed—SLC29A1—cerebellum—multiple sclerosis	0.000148	0.011	CbGeAlD
Pemetrexed—DCK—central nervous system—multiple sclerosis	0.000144	0.0108	CbGeAlD
Pemetrexed—DCK—cerebellum—multiple sclerosis	0.000141	0.0105	CbGeAlD
Pemetrexed—GART—Folate Metabolism—IFNG—multiple sclerosis	0.000136	0.0154	CbGpPWpGaD
Pemetrexed—TYMS—brain—multiple sclerosis	0.000134	0.01	CbGeAlD
Pemetrexed—DHFR—brain—multiple sclerosis	0.000132	0.0099	CbGeAlD
Pemetrexed—TYMS—E2F transcription factor network—RRM1—multiple sclerosis	0.000129	0.0145	CbGpPWpGaD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000128	0.0144	CbGpPWpGaD
Pemetrexed—TYMS—Nucleotide metabolism—RRM1—multiple sclerosis	0.000122	0.0138	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—IL4—multiple sclerosis	0.000122	0.0137	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—IL1B—multiple sclerosis	0.000122	0.0137	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—IL2—multiple sclerosis	0.000121	0.0137	CbGpPWpGaD
Pemetrexed—SLC29A1—brain—multiple sclerosis	0.00012	0.00897	CbGeAlD
Pemetrexed—DCK—brain—multiple sclerosis	0.000114	0.00857	CbGeAlD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000112	0.0126	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000112	0.0126	CbGpPWpGaD
Pemetrexed—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	9.96e-05	0.0112	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—ICAM1—multiple sclerosis	9.68e-05	0.0109	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—TNF—multiple sclerosis	8.83e-05	0.00994	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—CCL2—multiple sclerosis	8.67e-05	0.00976	CbGpPWpGaD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	8.5e-05	0.00957	CbGpPWpGaD
Pemetrexed—GART—Metabolism—SRM—multiple sclerosis	8.22e-05	0.00926	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—ALB—multiple sclerosis	8.07e-05	0.00909	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—IFNG—multiple sclerosis	7.37e-05	0.0083	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.19e-05	0.00809	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—IL6—multiple sclerosis	7.13e-05	0.00803	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—IL1B—multiple sclerosis	6.57e-05	0.0074	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—IL2—multiple sclerosis	6.55e-05	0.00737	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—IL4—multiple sclerosis	6.54e-05	0.00736	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	5.97e-05	0.00672	CbGpPWpGaD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	5.94e-05	0.00669	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CYP27B1—multiple sclerosis	5.79e-05	0.00653	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CYP24A1—multiple sclerosis	5.79e-05	0.00653	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—SRM—multiple sclerosis	5.7e-05	0.00642	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.7e-05	0.00642	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.45e-05	0.00613	CbGpPWpGaD
Pemetrexed—GART—Metabolism—GPC5—multiple sclerosis	5.3e-05	0.00597	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—ICAM1—multiple sclerosis	5.19e-05	0.00585	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—TNF—multiple sclerosis	4.77e-05	0.00537	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—CCL2—multiple sclerosis	4.65e-05	0.00523	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—SRM—multiple sclerosis	4.44e-05	0.005	CbGpPWpGaD
Pemetrexed—GART—Metabolism—RRM1—multiple sclerosis	4.39e-05	0.00495	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—ALB—multiple sclerosis	4.33e-05	0.00488	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.32e-05	0.00486	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.31e-05	0.00485	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CYP24A1—multiple sclerosis	4.02e-05	0.00452	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CYP27B1—multiple sclerosis	4.02e-05	0.00452	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—IFNG—multiple sclerosis	3.95e-05	0.00445	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—IL6—multiple sclerosis	3.85e-05	0.00433	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.81e-05	0.00429	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—GPC5—multiple sclerosis	3.67e-05	0.00414	CbGpPWpGaD
Pemetrexed—Erythema—Methylprednisolone—multiple sclerosis	3.65e-05	0.00131	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Prednisone—multiple sclerosis	3.64e-05	0.00131	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Prednisone—multiple sclerosis	3.62e-05	0.0013	CcSEcCtD
Pemetrexed—Myocardial infarction—Prednisone—multiple sclerosis	3.62e-05	0.0013	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	3.61e-05	0.00129	CcSEcCtD
Pemetrexed—Hypersensitivity—Azathioprine—multiple sclerosis	3.6e-05	0.00129	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	3.6e-05	0.00129	CcSEcCtD
Pemetrexed—Dysgeusia—Triamcinolone—multiple sclerosis	3.58e-05	0.00128	CcSEcCtD
Pemetrexed—Nausea—Cladribine—multiple sclerosis	3.57e-05	0.00128	CcSEcCtD
Pemetrexed—Syncope—Prednisolone—multiple sclerosis	3.56e-05	0.00128	CcSEcCtD
Pemetrexed—Eye disorder—Dexamethasone—multiple sclerosis	3.56e-05	0.00128	CcSEcCtD
Pemetrexed—Eye disorder—Betamethasone—multiple sclerosis	3.56e-05	0.00128	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—IL1B—multiple sclerosis	3.52e-05	0.00397	CbGpPWpGaD
Pemetrexed—Dyspnoea—Mitoxantrone—multiple sclerosis	3.52e-05	0.00126	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—IL2—multiple sclerosis	3.51e-05	0.00395	CbGpPWpGaD
Pemetrexed—Loss of consciousness—Prednisolone—multiple sclerosis	3.49e-05	0.00125	CcSEcCtD
Pemetrexed—Dyspepsia—Mitoxantrone—multiple sclerosis	3.48e-05	0.00125	CcSEcCtD
Pemetrexed—Decreased appetite—Mitoxantrone—multiple sclerosis	3.44e-05	0.00123	CcSEcCtD
Pemetrexed—Hypertension—Prednisolone—multiple sclerosis	3.43e-05	0.00123	CcSEcCtD
Pemetrexed—SLC46A1—Disease—GPC5—multiple sclerosis	3.42e-05	0.00385	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.41e-05	0.00384	CbGpPWpGaD
Pemetrexed—Fatigue—Mitoxantrone—multiple sclerosis	3.41e-05	0.00122	CcSEcCtD
Pemetrexed—Arrhythmia—Dexamethasone—multiple sclerosis	3.4e-05	0.00122	CcSEcCtD
Pemetrexed—Arrhythmia—Betamethasone—multiple sclerosis	3.4e-05	0.00122	CcSEcCtD
Pemetrexed—Pancreatitis—Methotrexate—multiple sclerosis	3.39e-05	0.00122	CcSEcCtD
Pemetrexed—Constipation—Mitoxantrone—multiple sclerosis	3.38e-05	0.00121	CcSEcCtD
Pemetrexed—Pain—Mitoxantrone—multiple sclerosis	3.38e-05	0.00121	CcSEcCtD
Pemetrexed—Alopecia—Dexamethasone—multiple sclerosis	3.37e-05	0.00121	CcSEcCtD
Pemetrexed—Alopecia—Betamethasone—multiple sclerosis	3.37e-05	0.00121	CcSEcCtD
Pemetrexed—Diarrhoea—Azathioprine—multiple sclerosis	3.35e-05	0.0012	CcSEcCtD
Pemetrexed—Erythema—Dexamethasone—multiple sclerosis	3.32e-05	0.00119	CcSEcCtD
Pemetrexed—Erythema—Betamethasone—multiple sclerosis	3.32e-05	0.00119	CcSEcCtD
Pemetrexed—Pancytopenia—Methotrexate—multiple sclerosis	3.29e-05	0.00118	CcSEcCtD
Pemetrexed—Syncope—Triamcinolone—multiple sclerosis	3.28e-05	0.00118	CcSEcCtD
Pemetrexed—Syncope—Methylprednisolone—multiple sclerosis	3.27e-05	0.00117	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.27e-05	0.00368	CbGpPWpGaD
Pemetrexed—Anaphylactic shock—Prednisolone—multiple sclerosis	3.24e-05	0.00116	CcSEcCtD
Pemetrexed—Oedema—Prednisolone—multiple sclerosis	3.24e-05	0.00116	CcSEcCtD
Pemetrexed—Neutropenia—Methotrexate—multiple sclerosis	3.24e-05	0.00116	CcSEcCtD
Pemetrexed—Dizziness—Azathioprine—multiple sclerosis	3.23e-05	0.00116	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	3.23e-05	0.00116	CcSEcCtD
Pemetrexed—Loss of consciousness—Triamcinolone—multiple sclerosis	3.21e-05	0.00115	CcSEcCtD
Pemetrexed—Loss of consciousness—Methylprednisolone—multiple sclerosis	3.2e-05	0.00115	CcSEcCtD
Pemetrexed—Shock—Prednisolone—multiple sclerosis	3.19e-05	0.00114	CcSEcCtD
Pemetrexed—Hypertension—Triamcinolone—multiple sclerosis	3.15e-05	0.00113	CcSEcCtD
Pemetrexed—Hypertension—Methylprednisolone—multiple sclerosis	3.15e-05	0.00113	CcSEcCtD
Pemetrexed—Urticaria—Mitoxantrone—multiple sclerosis	3.14e-05	0.00113	CcSEcCtD
Pemetrexed—TYMS—Azacitidine—Cladribine—multiple sclerosis	3.13e-05	0.0341	CbGdCrCtD
Pemetrexed—SLC46A1—Metabolism—CYP24A1—multiple sclerosis	3.13e-05	0.00352	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CYP27B1—multiple sclerosis	3.13e-05	0.00352	CbGpPWpGaD
Pemetrexed—Body temperature increased—Mitoxantrone—multiple sclerosis	3.12e-05	0.00112	CcSEcCtD
Pemetrexed—Abdominal pain—Mitoxantrone—multiple sclerosis	3.12e-05	0.00112	CcSEcCtD
Pemetrexed—Myalgia—Triamcinolone—multiple sclerosis	3.11e-05	0.00112	CcSEcCtD
Pemetrexed—Vomiting—Azathioprine—multiple sclerosis	3.11e-05	0.00111	CcSEcCtD
Pemetrexed—Myalgia—Methylprednisolone—multiple sclerosis	3.1e-05	0.00111	CcSEcCtD
Pemetrexed—Arthralgia—Methylprednisolone—multiple sclerosis	3.1e-05	0.00111	CcSEcCtD
Pemetrexed—Eye disorder—Prednisone—multiple sclerosis	3.1e-05	0.00111	CcSEcCtD
Pemetrexed—Infestation—Methotrexate—multiple sclerosis	3.09e-05	0.00111	CcSEcCtD
Pemetrexed—Infestation NOS—Methotrexate—multiple sclerosis	3.09e-05	0.00111	CcSEcCtD
Pemetrexed—Rash—Azathioprine—multiple sclerosis	3.08e-05	0.00111	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	3.08e-05	0.00111	CcSEcCtD
Pemetrexed—Dermatitis—Azathioprine—multiple sclerosis	3.08e-05	0.0011	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	3.06e-05	0.0011	CcSEcCtD
Pemetrexed—ATIC—Metabolism—RRM1—multiple sclerosis	3.04e-05	0.00343	CbGpPWpGaD
Pemetrexed—Renal failure—Methotrexate—multiple sclerosis	3.03e-05	0.00109	CcSEcCtD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.02e-05	0.0034	CbGpPWpGaD
Pemetrexed—Stomatitis—Methotrexate—multiple sclerosis	3.01e-05	0.00108	CcSEcCtD
Pemetrexed—Conjunctivitis—Methotrexate—multiple sclerosis	3e-05	0.00108	CcSEcCtD
Pemetrexed—Oedema—Triamcinolone—multiple sclerosis	2.98e-05	0.00107	CcSEcCtD
Pemetrexed—Anaphylactic shock—Triamcinolone—multiple sclerosis	2.98e-05	0.00107	CcSEcCtD
Pemetrexed—Anaphylactic shock—Methylprednisolone—multiple sclerosis	2.98e-05	0.00107	CcSEcCtD
Pemetrexed—Syncope—Dexamethasone—multiple sclerosis	2.97e-05	0.00107	CcSEcCtD
Pemetrexed—Syncope—Betamethasone—multiple sclerosis	2.97e-05	0.00107	CcSEcCtD
Pemetrexed—DCK—Metabolism—SRM—multiple sclerosis	2.96e-05	0.00334	CbGpPWpGaD
Pemetrexed—Arrhythmia—Prednisone—multiple sclerosis	2.96e-05	0.00106	CcSEcCtD
Pemetrexed—Infection—Triamcinolone—multiple sclerosis	2.96e-05	0.00106	CcSEcCtD
Pemetrexed—Infection—Methylprednisolone—multiple sclerosis	2.96e-05	0.00106	CcSEcCtD
Pemetrexed—Shock—Triamcinolone—multiple sclerosis	2.93e-05	0.00105	CcSEcCtD
Pemetrexed—Alopecia—Prednisone—multiple sclerosis	2.93e-05	0.00105	CcSEcCtD
Pemetrexed—Shock—Methylprednisolone—multiple sclerosis	2.93e-05	0.00105	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Methotrexate—multiple sclerosis	2.92e-05	0.00105	CcSEcCtD
Pemetrexed—Nervous system disorder—Methylprednisolone—multiple sclerosis	2.92e-05	0.00105	CcSEcCtD
Pemetrexed—Loss of consciousness—Betamethasone—multiple sclerosis	2.91e-05	0.00105	CcSEcCtD
Pemetrexed—Loss of consciousness—Dexamethasone—multiple sclerosis	2.91e-05	0.00105	CcSEcCtD
Pemetrexed—Hypersensitivity—Mitoxantrone—multiple sclerosis	2.91e-05	0.00104	CcSEcCtD
Pemetrexed—Nausea—Azathioprine—multiple sclerosis	2.9e-05	0.00104	CcSEcCtD
Pemetrexed—Skin disorder—Methylprednisolone—multiple sclerosis	2.89e-05	0.00104	CcSEcCtD
Pemetrexed—Erythema—Prednisone—multiple sclerosis	2.89e-05	0.00104	CcSEcCtD
Pemetrexed—Malnutrition—Prednisone—multiple sclerosis	2.89e-05	0.00104	CcSEcCtD
Pemetrexed—Agranulocytosis—Methotrexate—multiple sclerosis	2.88e-05	0.00103	CcSEcCtD
Pemetrexed—Hypertension—Betamethasone—multiple sclerosis	2.86e-05	0.00103	CcSEcCtD
Pemetrexed—Hypertension—Dexamethasone—multiple sclerosis	2.86e-05	0.00103	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—GPC5—multiple sclerosis	2.86e-05	0.00322	CbGpPWpGaD
Pemetrexed—Asthenia—Mitoxantrone—multiple sclerosis	2.84e-05	0.00102	CcSEcCtD
Pemetrexed—Myalgia—Dexamethasone—multiple sclerosis	2.82e-05	0.00101	CcSEcCtD
Pemetrexed—Myalgia—Betamethasone—multiple sclerosis	2.82e-05	0.00101	CcSEcCtD
Pemetrexed—Pain—Prednisolone—multiple sclerosis	2.77e-05	0.000995	CcSEcCtD
Pemetrexed—Hepatitis—Methotrexate—multiple sclerosis	2.77e-05	0.000994	CcSEcCtD
Pemetrexed—Pharyngitis—Methotrexate—multiple sclerosis	2.75e-05	0.000987	CcSEcCtD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	2.74e-05	0.00308	CbGpPWpGaD
Pemetrexed—Urinary tract disorder—Methotrexate—multiple sclerosis	2.74e-05	0.000982	CcSEcCtD
Pemetrexed—Urethral disorder—Methotrexate—multiple sclerosis	2.72e-05	0.000974	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	2.72e-05	0.000974	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	2.71e-05	0.000972	CcSEcCtD
Pemetrexed—Oedema—Betamethasone—multiple sclerosis	2.71e-05	0.00097	CcSEcCtD
Pemetrexed—Anaphylactic shock—Dexamethasone—multiple sclerosis	2.71e-05	0.00097	CcSEcCtD
Pemetrexed—Oedema—Dexamethasone—multiple sclerosis	2.71e-05	0.00097	CcSEcCtD
Pemetrexed—Anaphylactic shock—Betamethasone—multiple sclerosis	2.71e-05	0.00097	CcSEcCtD
Pemetrexed—Diarrhoea—Mitoxantrone—multiple sclerosis	2.7e-05	0.00097	CcSEcCtD
Pemetrexed—Infection—Dexamethasone—multiple sclerosis	2.69e-05	0.000964	CcSEcCtD
Pemetrexed—Infection—Betamethasone—multiple sclerosis	2.69e-05	0.000964	CcSEcCtD
Pemetrexed—Anaemia—Prednisone—multiple sclerosis	2.67e-05	0.000957	CcSEcCtD
Pemetrexed—Shock—Betamethasone—multiple sclerosis	2.66e-05	0.000955	CcSEcCtD
Pemetrexed—Shock—Dexamethasone—multiple sclerosis	2.66e-05	0.000955	CcSEcCtD
Pemetrexed—Dyspnoea—Triamcinolone—multiple sclerosis	2.66e-05	0.000953	CcSEcCtD
Pemetrexed—Nervous system disorder—Dexamethasone—multiple sclerosis	2.65e-05	0.000952	CcSEcCtD
Pemetrexed—Nervous system disorder—Betamethasone—multiple sclerosis	2.65e-05	0.000952	CcSEcCtD
Pemetrexed—Thrombocytopenia—Betamethasone—multiple sclerosis	2.65e-05	0.00095	CcSEcCtD
Pemetrexed—Thrombocytopenia—Dexamethasone—multiple sclerosis	2.65e-05	0.00095	CcSEcCtD
Pemetrexed—Dyspepsia—Triamcinolone—multiple sclerosis	2.62e-05	0.000941	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.62e-05	0.00296	CbGpPWpGaD
Pemetrexed—Erythema multiforme—Methotrexate—multiple sclerosis	2.62e-05	0.00094	CcSEcCtD
Pemetrexed—Dyspepsia—Methylprednisolone—multiple sclerosis	2.62e-05	0.000939	CcSEcCtD
Pemetrexed—Eye disorder—Methotrexate—multiple sclerosis	2.59e-05	0.000929	CcSEcCtD
Pemetrexed—Syncope—Prednisone—multiple sclerosis	2.59e-05	0.000929	CcSEcCtD
Pemetrexed—Anorexia—Betamethasone—multiple sclerosis	2.58e-05	0.000925	CcSEcCtD
Pemetrexed—Anorexia—Dexamethasone—multiple sclerosis	2.58e-05	0.000925	CcSEcCtD
Pemetrexed—Urticaria—Prednisolone—multiple sclerosis	2.58e-05	0.000924	CcSEcCtD
Pemetrexed—Fatigue—Triamcinolone—multiple sclerosis	2.57e-05	0.000922	CcSEcCtD
Pemetrexed—Fatigue—Methylprednisolone—multiple sclerosis	2.57e-05	0.00092	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—TNF—multiple sclerosis	2.56e-05	0.00288	CbGpPWpGaD
Pemetrexed—Pain—Triamcinolone—multiple sclerosis	2.55e-05	0.000915	CcSEcCtD
Pemetrexed—Loss of consciousness—Prednisone—multiple sclerosis	2.54e-05	0.00091	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—MYC—multiple sclerosis	2.53e-05	0.00285	CbGpPWpGaD
Pemetrexed—GART—Metabolism—BCHE—multiple sclerosis	2.52e-05	0.00284	CbGpPWpGaD
Pemetrexed—Vomiting—Mitoxantrone—multiple sclerosis	2.51e-05	0.000901	CcSEcCtD
Pemetrexed—Hypertension—Prednisone—multiple sclerosis	2.49e-05	0.000894	CcSEcCtD
Pemetrexed—Rash—Mitoxantrone—multiple sclerosis	2.49e-05	0.000894	CcSEcCtD
Pemetrexed—Dermatitis—Mitoxantrone—multiple sclerosis	2.49e-05	0.000893	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Methylprednisolone—multiple sclerosis	2.48e-05	0.027	CbGdCrCtD
Pemetrexed—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	2.46e-05	0.000884	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	2.46e-05	0.000884	CcSEcCtD
Pemetrexed—Arthralgia—Prednisone—multiple sclerosis	2.46e-05	0.000882	CcSEcCtD
Pemetrexed—Myalgia—Prednisone—multiple sclerosis	2.46e-05	0.000882	CcSEcCtD
Pemetrexed—Alopecia—Methotrexate—multiple sclerosis	2.45e-05	0.000878	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	2.44e-05	0.000876	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Betamethasone—multiple sclerosis	2.44e-05	0.0266	CbGdCrCtD
Pemetrexed—DCK—Desoximetasone—Dexamethasone—multiple sclerosis	2.44e-05	0.0266	CbGdCrCtD
Pemetrexed—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	2.43e-05	0.000873	CcSEcCtD
Pemetrexed—Malnutrition—Methotrexate—multiple sclerosis	2.41e-05	0.000865	CcSEcCtD
Pemetrexed—Erythema—Methotrexate—multiple sclerosis	2.41e-05	0.000865	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Methylprednisolone—multiple sclerosis	2.41e-05	0.0262	CbGdCrCtD
Pemetrexed—Hypersensitivity—Prednisolone—multiple sclerosis	2.39e-05	0.000857	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Triamcinolone—multiple sclerosis	2.38e-05	0.026	CbGdCrCtD
Pemetrexed—Dyspepsia—Betamethasone—multiple sclerosis	2.38e-05	0.000854	CcSEcCtD
Pemetrexed—Dyspepsia—Dexamethasone—multiple sclerosis	2.38e-05	0.000854	CcSEcCtD
Pemetrexed—DHFR—Metabolism—SRM—multiple sclerosis	2.38e-05	0.00268	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—RRM1—multiple sclerosis	2.37e-05	0.00267	CbGpPWpGaD
Pemetrexed—Urticaria—Triamcinolone—multiple sclerosis	2.37e-05	0.00085	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Dexamethasone—multiple sclerosis	2.37e-05	0.0258	CbGdCrCtD
Pemetrexed—DCK—Diflorasone—Betamethasone—multiple sclerosis	2.37e-05	0.0258	CbGdCrCtD
Pemetrexed—Urticaria—Methylprednisolone—multiple sclerosis	2.36e-05	0.000848	CcSEcCtD
Pemetrexed—Dysgeusia—Methotrexate—multiple sclerosis	2.36e-05	0.000847	CcSEcCtD
Pemetrexed—Body temperature increased—Triamcinolone—multiple sclerosis	2.36e-05	0.000845	CcSEcCtD
Pemetrexed—Anaphylactic shock—Prednisone—multiple sclerosis	2.36e-05	0.000845	CcSEcCtD
Pemetrexed—Oedema—Prednisone—multiple sclerosis	2.36e-05	0.000845	CcSEcCtD
Pemetrexed—Abdominal pain—Methylprednisolone—multiple sclerosis	2.35e-05	0.000844	CcSEcCtD
Pemetrexed—Decreased appetite—Betamethasone—multiple sclerosis	2.35e-05	0.000844	CcSEcCtD
Pemetrexed—Decreased appetite—Dexamethasone—multiple sclerosis	2.35e-05	0.000844	CcSEcCtD
Pemetrexed—Nausea—Mitoxantrone—multiple sclerosis	2.35e-05	0.000842	CcSEcCtD
Pemetrexed—Infection—Prednisone—multiple sclerosis	2.34e-05	0.00084	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Betamethasone—multiple sclerosis	2.34e-05	0.000838	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	2.34e-05	0.000838	CcSEcCtD
Pemetrexed—Fatigue—Betamethasone—multiple sclerosis	2.33e-05	0.000837	CcSEcCtD
Pemetrexed—Fatigue—Dexamethasone—multiple sclerosis	2.33e-05	0.000837	CcSEcCtD
Pemetrexed—Shock—Prednisone—multiple sclerosis	2.32e-05	0.000831	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Triamcinolone—multiple sclerosis	2.31e-05	0.0252	CbGdCrCtD
Pemetrexed—Pain—Dexamethasone—multiple sclerosis	2.31e-05	0.00083	CcSEcCtD
Pemetrexed—Pain—Betamethasone—multiple sclerosis	2.31e-05	0.00083	CcSEcCtD
Pemetrexed—Nervous system disorder—Prednisone—multiple sclerosis	2.31e-05	0.000829	CcSEcCtD
Pemetrexed—Skin disorder—Prednisone—multiple sclerosis	2.29e-05	0.000821	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Prednisone—multiple sclerosis	2.26e-05	0.0246	CbGdCrCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.25e-05	0.00253	CbGpPWpGaD
Pemetrexed—Anorexia—Prednisone—multiple sclerosis	2.25e-05	0.000806	CcSEcCtD
Pemetrexed—Anaemia—Methotrexate—multiple sclerosis	2.23e-05	0.0008	CcSEcCtD
Pemetrexed—SLC46A1—Disease—RPL5—multiple sclerosis	2.22e-05	0.0025	CbGpPWpGaD
Pemetrexed—Gastrointestinal pain—Betamethasone—multiple sclerosis	2.21e-05	0.000794	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Dexamethasone—multiple sclerosis	2.21e-05	0.000794	CcSEcCtD
Pemetrexed—TYMS—E2F transcription factor network—MYC—multiple sclerosis	2.21e-05	0.00249	CbGpPWpGaD
Pemetrexed—DCK—Desoximetasone—Prednisolone—multiple sclerosis	2.21e-05	0.024	CbGdCrCtD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	2.2e-05	0.00248	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Triamcinolone—multiple sclerosis	2.2e-05	0.000788	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Prednisone—multiple sclerosis	2.2e-05	0.0239	CbGdCrCtD
Pemetrexed—Hypersensitivity—Methylprednisolone—multiple sclerosis	2.19e-05	0.000786	CcSEcCtD
Pemetrexed—Leukopenia—Methotrexate—multiple sclerosis	2.16e-05	0.000775	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—FAS—multiple sclerosis	2.16e-05	0.00243	CbGpPWpGaD
Pemetrexed—Urticaria—Betamethasone—multiple sclerosis	2.15e-05	0.000771	CcSEcCtD
Pemetrexed—Urticaria—Dexamethasone—multiple sclerosis	2.15e-05	0.000771	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Prednisone—multiple sclerosis	2.15e-05	0.00077	CcSEcCtD
Pemetrexed—Dizziness—Prednisolone—multiple sclerosis	2.14e-05	0.000769	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Prednisolone—multiple sclerosis	2.14e-05	0.0233	CbGdCrCtD
Pemetrexed—Asthenia—Triamcinolone—multiple sclerosis	2.14e-05	0.000767	CcSEcCtD
Pemetrexed—Body temperature increased—Dexamethasone—multiple sclerosis	2.14e-05	0.000767	CcSEcCtD
Pemetrexed—Abdominal pain—Betamethasone—multiple sclerosis	2.14e-05	0.000767	CcSEcCtD
Pemetrexed—Abdominal pain—Dexamethasone—multiple sclerosis	2.14e-05	0.000767	CcSEcCtD
Pemetrexed—Body temperature increased—Betamethasone—multiple sclerosis	2.14e-05	0.000767	CcSEcCtD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.14e-05	0.00241	CbGpPWpGaD
Pemetrexed—Asthenia—Methylprednisolone—multiple sclerosis	2.13e-05	0.000766	CcSEcCtD
Pemetrexed—SLC46A1—Disease—SLC11A1—multiple sclerosis	2.13e-05	0.0024	CbGpPWpGaD
Pemetrexed—Pruritus—Triamcinolone—multiple sclerosis	2.11e-05	0.000757	CcSEcCtD
Pemetrexed—Pruritus—Methylprednisolone—multiple sclerosis	2.1e-05	0.000755	CcSEcCtD
Pemetrexed—DCK—Metabolism—CYP24A1—multiple sclerosis	2.09e-05	0.00235	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP27B1—multiple sclerosis	2.09e-05	0.00235	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SRM—multiple sclerosis	2.08e-05	0.00234	CbGpPWpGaD
Pemetrexed—Dyspepsia—Prednisone—multiple sclerosis	2.07e-05	0.000744	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—IL6—multiple sclerosis	2.06e-05	0.00232	CbGpPWpGaD
Pemetrexed—Arthralgia—Methotrexate—multiple sclerosis	2.05e-05	0.000737	CcSEcCtD
Pemetrexed—Myalgia—Methotrexate—multiple sclerosis	2.05e-05	0.000737	CcSEcCtD
Pemetrexed—Chest pain—Methotrexate—multiple sclerosis	2.05e-05	0.000737	CcSEcCtD
Pemetrexed—Decreased appetite—Prednisone—multiple sclerosis	2.05e-05	0.000735	CcSEcCtD
Pemetrexed—Rash—Prednisolone—multiple sclerosis	2.04e-05	0.000733	CcSEcCtD
Pemetrexed—Dermatitis—Prednisolone—multiple sclerosis	2.04e-05	0.000733	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	2.04e-05	0.000732	CcSEcCtD
Pemetrexed—Diarrhoea—Methylprednisolone—multiple sclerosis	2.04e-05	0.00073	CcSEcCtD
Pemetrexed—Fatigue—Prednisone—multiple sclerosis	2.03e-05	0.000729	CcSEcCtD
Pemetrexed—Constipation—Prednisone—multiple sclerosis	2.01e-05	0.000723	CcSEcCtD
Pemetrexed—TYMS—Clobetasol propionate—Methylprednisolone—multiple sclerosis	2.01e-05	0.0219	CbGdCrCtD
Pemetrexed—TYMS—Flunisolide—Methylprednisolone—multiple sclerosis	1.99e-05	0.0216	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Dexamethasone—multiple sclerosis	1.98e-05	0.0216	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Betamethasone—multiple sclerosis	1.98e-05	0.0216	CbGdCrCtD
Pemetrexed—Dizziness—Triamcinolone—multiple sclerosis	1.97e-05	0.000707	CcSEcCtD
Pemetrexed—Anaphylactic shock—Methotrexate—multiple sclerosis	1.97e-05	0.000706	CcSEcCtD
Pemetrexed—Dizziness—Methylprednisolone—multiple sclerosis	1.97e-05	0.000706	CcSEcCtD
Pemetrexed—TYMS—Triamcinolone—Methylprednisolone—multiple sclerosis	1.97e-05	0.0214	CbGdCrCtD
Pemetrexed—Infection—Methotrexate—multiple sclerosis	1.96e-05	0.000702	CcSEcCtD
Pemetrexed—TYMS—Flunisolide—Dexamethasone—multiple sclerosis	1.95e-05	0.0213	CbGdCrCtD
Pemetrexed—TYMS—Flunisolide—Betamethasone—multiple sclerosis	1.95e-05	0.0213	CbGdCrCtD
Pemetrexed—Asthenia—Betamethasone—multiple sclerosis	1.94e-05	0.000696	CcSEcCtD
Pemetrexed—Asthenia—Dexamethasone—multiple sclerosis	1.94e-05	0.000696	CcSEcCtD
Pemetrexed—TYMS—Clobetasol propionate—Triamcinolone—multiple sclerosis	1.94e-05	0.0211	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Dexamethasone—multiple sclerosis	1.93e-05	0.0211	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Betamethasone—multiple sclerosis	1.93e-05	0.0211	CbGdCrCtD
Pemetrexed—Nervous system disorder—Methotrexate—multiple sclerosis	1.93e-05	0.000693	CcSEcCtD
Pemetrexed—Thrombocytopenia—Methotrexate—multiple sclerosis	1.93e-05	0.000692	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Prednisone—multiple sclerosis	1.93e-05	0.000691	CcSEcCtD
Pemetrexed—Nausea—Prednisolone—multiple sclerosis	1.93e-05	0.000691	CcSEcCtD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	1.92e-05	0.00216	CbGpPWpGaD
Pemetrexed—TYMS—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	1.92e-05	0.0209	CbGdCrCtD
Pemetrexed—Pruritus—Dexamethasone—multiple sclerosis	1.91e-05	0.000687	CcSEcCtD
Pemetrexed—Pruritus—Betamethasone—multiple sclerosis	1.91e-05	0.000687	CcSEcCtD
Pemetrexed—Skin disorder—Methotrexate—multiple sclerosis	1.91e-05	0.000686	CcSEcCtD
Pemetrexed—TYMS—Flunisolide—Triamcinolone—multiple sclerosis	1.91e-05	0.0208	CbGdCrCtD
Pemetrexed—DCK—Metabolism—GPC5—multiple sclerosis	1.91e-05	0.00215	CbGpPWpGaD
Pemetrexed—Vomiting—Triamcinolone—multiple sclerosis	1.9e-05	0.00068	CcSEcCtD
Pemetrexed—Vomiting—Methylprednisolone—multiple sclerosis	1.89e-05	0.000678	CcSEcCtD
Pemetrexed—TYMS—Fluticasone Propionate—Dexamethasone—multiple sclerosis	1.89e-05	0.0205	CbGdCrCtD
Pemetrexed—TYMS—Fluticasone Propionate—Betamethasone—multiple sclerosis	1.89e-05	0.0205	CbGdCrCtD
Pemetrexed—Rash—Triamcinolone—multiple sclerosis	1.88e-05	0.000674	CcSEcCtD
Pemetrexed—Dermatitis—Triamcinolone—multiple sclerosis	1.88e-05	0.000674	CcSEcCtD
Pemetrexed—Anorexia—Methotrexate—multiple sclerosis	1.88e-05	0.000673	CcSEcCtD
Pemetrexed—Rash—Methylprednisolone—multiple sclerosis	1.88e-05	0.000673	CcSEcCtD
Pemetrexed—Dermatitis—Methylprednisolone—multiple sclerosis	1.87e-05	0.000672	CcSEcCtD
Pemetrexed—Urticaria—Prednisone—multiple sclerosis	1.87e-05	0.000671	CcSEcCtD
Pemetrexed—Body temperature increased—Prednisone—multiple sclerosis	1.86e-05	0.000668	CcSEcCtD
Pemetrexed—Abdominal pain—Prednisone—multiple sclerosis	1.86e-05	0.000668	CcSEcCtD
Pemetrexed—Diarrhoea—Dexamethasone—multiple sclerosis	1.85e-05	0.000664	CcSEcCtD
Pemetrexed—Diarrhoea—Betamethasone—multiple sclerosis	1.85e-05	0.000664	CcSEcCtD
Pemetrexed—TYMS—Fluticasone Propionate—Triamcinolone—multiple sclerosis	1.84e-05	0.0201	CbGdCrCtD
Pemetrexed—DHFR—G1/S Transition—MYC—multiple sclerosis	1.84e-05	0.00207	CbGpPWpGaD
Pemetrexed—TYMS—Clobetasol propionate—Prednisone—multiple sclerosis	1.84e-05	0.02	CbGdCrCtD
Pemetrexed—DHFR—Disease—GPC5—multiple sclerosis	1.83e-05	0.00206	CbGpPWpGaD
Pemetrexed—TYMS—Flunisolide—Prednisone—multiple sclerosis	1.81e-05	0.0197	CbGdCrCtD
Pemetrexed—TYMS—Diflorasone—Methylprednisolone—multiple sclerosis	1.81e-05	0.0197	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Prednisone—multiple sclerosis	1.79e-05	0.0195	CbGdCrCtD
Pemetrexed—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	1.79e-05	0.000643	CcSEcCtD
Pemetrexed—TYMS—Clobetasol propionate—Prednisolone—multiple sclerosis	1.79e-05	0.0195	CbGdCrCtD
Pemetrexed—Dizziness—Betamethasone—multiple sclerosis	1.79e-05	0.000642	CcSEcCtD
Pemetrexed—Dizziness—Dexamethasone—multiple sclerosis	1.79e-05	0.000642	CcSEcCtD
Pemetrexed—TYMS—Diflorasone—Dexamethasone—multiple sclerosis	1.78e-05	0.0194	CbGdCrCtD
Pemetrexed—TYMS—Diflorasone—Betamethasone—multiple sclerosis	1.78e-05	0.0194	CbGdCrCtD
Pemetrexed—Nausea—Triamcinolone—multiple sclerosis	1.77e-05	0.000635	CcSEcCtD
Pemetrexed—TYMS—Flunisolide—Prednisolone—multiple sclerosis	1.77e-05	0.0193	CbGdCrCtD
Pemetrexed—Nausea—Methylprednisolone—multiple sclerosis	1.77e-05	0.000634	CcSEcCtD
Pemetrexed—Dyspnoea—Methotrexate—multiple sclerosis	1.76e-05	0.00063	CcSEcCtD
Pemetrexed—TYMS—Triamcinolone—Prednisolone—multiple sclerosis	1.75e-05	0.0191	CbGdCrCtD
Pemetrexed—ATIC—Metabolism—BCHE—multiple sclerosis	1.75e-05	0.00197	CbGpPWpGaD
Pemetrexed—TYMS—Diflorasone—Triamcinolone—multiple sclerosis	1.74e-05	0.019	CbGdCrCtD
Pemetrexed—Hypersensitivity—Prednisone—multiple sclerosis	1.74e-05	0.000623	CcSEcCtD
Pemetrexed—Dyspepsia—Methotrexate—multiple sclerosis	1.73e-05	0.000622	CcSEcCtD
Pemetrexed—Vomiting—Dexamethasone—multiple sclerosis	1.72e-05	0.000617	CcSEcCtD
Pemetrexed—Vomiting—Betamethasone—multiple sclerosis	1.72e-05	0.000617	CcSEcCtD
Pemetrexed—Decreased appetite—Methotrexate—multiple sclerosis	1.71e-05	0.000614	CcSEcCtD
Pemetrexed—Rash—Betamethasone—multiple sclerosis	1.71e-05	0.000612	CcSEcCtD
Pemetrexed—Rash—Dexamethasone—multiple sclerosis	1.71e-05	0.000612	CcSEcCtD
Pemetrexed—Dermatitis—Betamethasone—multiple sclerosis	1.7e-05	0.000611	CcSEcCtD
Pemetrexed—Dermatitis—Dexamethasone—multiple sclerosis	1.7e-05	0.000611	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Methotrexate—multiple sclerosis	1.7e-05	0.00061	CcSEcCtD
Pemetrexed—SLC46A1—Disease—CD28—multiple sclerosis	1.7e-05	0.00191	CbGpPWpGaD
Pemetrexed—Fatigue—Methotrexate—multiple sclerosis	1.7e-05	0.000609	CcSEcCtD
Pemetrexed—Asthenia—Prednisone—multiple sclerosis	1.69e-05	0.000606	CcSEcCtD
Pemetrexed—Pain—Methotrexate—multiple sclerosis	1.68e-05	0.000604	CcSEcCtD
Pemetrexed—DHFR—Metabolism—CYP27B1—multiple sclerosis	1.68e-05	0.00189	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP24A1—multiple sclerosis	1.68e-05	0.00189	CbGpPWpGaD
Pemetrexed—Pruritus—Prednisone—multiple sclerosis	1.67e-05	0.000598	CcSEcCtD
Pemetrexed—TYMS—Diflorasone—Prednisone—multiple sclerosis	1.65e-05	0.018	CbGdCrCtD
Pemetrexed—TYMS—Diflorasone—Prednisolone—multiple sclerosis	1.61e-05	0.0176	CbGdCrCtD
Pemetrexed—Diarrhoea—Prednisone—multiple sclerosis	1.61e-05	0.000578	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Methotrexate—multiple sclerosis	1.61e-05	0.000578	CcSEcCtD
Pemetrexed—Nausea—Betamethasone—multiple sclerosis	1.61e-05	0.000576	CcSEcCtD
Pemetrexed—Nausea—Dexamethasone—multiple sclerosis	1.61e-05	0.000576	CcSEcCtD
Pemetrexed—TYMS—G1/S Transition—MYC—multiple sclerosis	1.6e-05	0.00181	CbGpPWpGaD
Pemetrexed—TYMS—Budesonide—Methylprednisolone—multiple sclerosis	1.59e-05	0.0173	CbGdCrCtD
Pemetrexed—DCK—Metabolism—RRM1—multiple sclerosis	1.58e-05	0.00178	CbGpPWpGaD
Pemetrexed—Urticaria—Methotrexate—multiple sclerosis	1.56e-05	0.000561	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Dexamethasone—multiple sclerosis	1.56e-05	0.017	CbGdCrCtD
Pemetrexed—TYMS—Budesonide—Betamethasone—multiple sclerosis	1.56e-05	0.017	CbGdCrCtD
Pemetrexed—Dizziness—Prednisone—multiple sclerosis	1.56e-05	0.000559	CcSEcCtD
Pemetrexed—Body temperature increased—Methotrexate—multiple sclerosis	1.56e-05	0.000558	CcSEcCtD
Pemetrexed—Abdominal pain—Methotrexate—multiple sclerosis	1.56e-05	0.000558	CcSEcCtD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—MYC—multiple sclerosis	1.55e-05	0.00174	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GPC5—multiple sclerosis	1.53e-05	0.00173	CbGpPWpGaD
Pemetrexed—TYMS—Budesonide—Triamcinolone—multiple sclerosis	1.53e-05	0.0166	CbGdCrCtD
Pemetrexed—GART—Metabolism—APOE—multiple sclerosis	1.52e-05	0.00171	CbGpPWpGaD
Pemetrexed—Vomiting—Prednisone—multiple sclerosis	1.5e-05	0.000537	CcSEcCtD
Pemetrexed—Rash—Prednisone—multiple sclerosis	1.49e-05	0.000533	CcSEcCtD
Pemetrexed—Dermatitis—Prednisone—multiple sclerosis	1.48e-05	0.000532	CcSEcCtD
Pemetrexed—TYMS—Metabolism—CYP24A1—multiple sclerosis	1.46e-05	0.00165	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP27B1—multiple sclerosis	1.46e-05	0.00165	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Methotrexate—multiple sclerosis	1.45e-05	0.00052	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Prednisone—multiple sclerosis	1.45e-05	0.0158	CbGdCrCtD
Pemetrexed—TYMS—Budesonide—Prednisolone—multiple sclerosis	1.42e-05	0.0154	CbGdCrCtD
Pemetrexed—Asthenia—Methotrexate—multiple sclerosis	1.41e-05	0.000507	CcSEcCtD
Pemetrexed—Nausea—Prednisone—multiple sclerosis	1.4e-05	0.000502	CcSEcCtD
Pemetrexed—Pruritus—Methotrexate—multiple sclerosis	1.39e-05	0.0005	CcSEcCtD
Pemetrexed—TYMS—Danazol—Prednisone—multiple sclerosis	1.39e-05	0.0151	CbGdCrCtD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.37e-05	0.00154	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—BCHE—multiple sclerosis	1.36e-05	0.00153	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—MYC—multiple sclerosis	1.35e-05	0.00152	CbGpPWpGaD
Pemetrexed—Diarrhoea—Methotrexate—multiple sclerosis	1.35e-05	0.000483	CcSEcCtD
Pemetrexed—TYMS—Metabolism—GPC5—multiple sclerosis	1.34e-05	0.00151	CbGpPWpGaD
Pemetrexed—GART—Metabolism—POMC—multiple sclerosis	1.3e-05	0.00147	CbGpPWpGaD
Pemetrexed—Dizziness—Methotrexate—multiple sclerosis	1.3e-05	0.000467	CcSEcCtD
Pemetrexed—DHFR—Metabolism—RRM1—multiple sclerosis	1.27e-05	0.00143	CbGpPWpGaD
Pemetrexed—Vomiting—Methotrexate—multiple sclerosis	1.25e-05	0.000449	CcSEcCtD
Pemetrexed—Rash—Methotrexate—multiple sclerosis	1.24e-05	0.000445	CcSEcCtD
Pemetrexed—Dermatitis—Methotrexate—multiple sclerosis	1.24e-05	0.000445	CcSEcCtD
Pemetrexed—SLC46A1—Disease—CD86—multiple sclerosis	1.21e-05	0.00137	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RPL5—multiple sclerosis	1.19e-05	0.00134	CbGpPWpGaD
Pemetrexed—GART—Metabolism—ALB—multiple sclerosis	1.19e-05	0.00134	CbGpPWpGaD
Pemetrexed—Nausea—Methotrexate—multiple sclerosis	1.17e-05	0.00042	CcSEcCtD
Pemetrexed—DHFR—Disease—SLC11A1—multiple sclerosis	1.14e-05	0.00129	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—RRM1—multiple sclerosis	1.11e-05	0.00125	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.09e-05	0.00122	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CCR5—multiple sclerosis	1.08e-05	0.00121	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—APOE—multiple sclerosis	1.05e-05	0.00118	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HLA-A—multiple sclerosis	1.05e-05	0.00118	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.02e-05	0.00115	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.02e-05	0.00115	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1e-05	0.00113	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—APOE—multiple sclerosis	9.78e-06	0.0011	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.54e-06	0.00107	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CD28—multiple sclerosis	9.11e-06	0.00103	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—BCHE—multiple sclerosis	9.09e-06	0.00102	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—POMC—multiple sclerosis	9.03e-06	0.00102	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CD80—multiple sclerosis	8.85e-06	0.000996	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ALB—multiple sclerosis	8.24e-06	0.000928	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—APOE—multiple sclerosis	8.19e-06	0.000923	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—TYK2—multiple sclerosis	7.47e-06	0.000841	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—IL6—multiple sclerosis	7.39e-06	0.000832	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—BCHE—multiple sclerosis	7.3e-06	0.000822	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—POMC—multiple sclerosis	7.04e-06	0.000793	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CD4—multiple sclerosis	6.75e-06	0.00076	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CD86—multiple sclerosis	6.5e-06	0.000732	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ALB—multiple sclerosis	6.42e-06	0.000723	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—BCHE—multiple sclerosis	6.37e-06	0.000718	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CCR5—multiple sclerosis	5.77e-06	0.000649	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MYC—multiple sclerosis	5.68e-06	0.00064	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HLA-A—multiple sclerosis	5.62e-06	0.000633	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	5.56e-06	0.000626	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—APOE—multiple sclerosis	5.47e-06	0.000616	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APOE—multiple sclerosis	5.25e-06	0.000591	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—STAT3—multiple sclerosis	5.23e-06	0.000589	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MYC—multiple sclerosis	5.08e-06	0.000572	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MAPK1—multiple sclerosis	4.97e-06	0.000559	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MYC—multiple sclerosis	4.96e-06	0.000558	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MYC—multiple sclerosis	4.86e-06	0.000547	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	4.85e-06	0.000546	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—TGFB1—multiple sclerosis	4.85e-06	0.000546	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MAPK1—multiple sclerosis	4.75e-06	0.000535	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CD80—multiple sclerosis	4.74e-06	0.000534	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—POMC—multiple sclerosis	4.7e-06	0.000529	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MYC—multiple sclerosis	4.43e-06	0.000499	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—APOE—multiple sclerosis	4.39e-06	0.000495	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MAPK1—multiple sclerosis	4.33e-06	0.000488	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ALB—multiple sclerosis	4.28e-06	0.000482	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TYK2—multiple sclerosis	4e-06	0.000451	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—APOE—multiple sclerosis	3.83e-06	0.000432	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—POMC—multiple sclerosis	3.77e-06	0.000425	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6—multiple sclerosis	3.65e-06	0.000411	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CD4—multiple sclerosis	3.62e-06	0.000408	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ALB—multiple sclerosis	3.44e-06	0.000387	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—POMC—multiple sclerosis	3.29e-06	0.000371	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALB—multiple sclerosis	3e-06	0.000338	CbGpPWpGaD
Pemetrexed—DHFR—Disease—STAT3—multiple sclerosis	2.8e-06	0.000316	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MYC—multiple sclerosis	2.61e-06	0.000293	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TGFB1—multiple sclerosis	2.6e-06	0.000293	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MAPK1—multiple sclerosis	2.55e-06	0.000287	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6—multiple sclerosis	1.96e-06	0.000221	CbGpPWpGaD
